Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical StudyYan Xu, Huimian Xu, Rupeng Zhang et al.|Frontiers in Oncology|2021Cited by 7
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC).Qiang Xue, Han Liang, Baogui Wang et al.|Journal of Clinical Oncology|2021Cited by 6
151P CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with doublet chemotherapy (Nab-PTX & S-1) and apatinib (anti-angiogenic TKI) for the first-line treatment of stage IV gastric cancer (GC)Qian‐Li Xue, Han Liang, B. Wang et al.|Annals of Oncology|2021Cited by 3
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage <scp>IV</scp> gastric cancerYong Liu, Han Liang, Qiang Xue et al.|International Journal of Cancer|2025Cited by 3
Editorial BoardChristoph-Thomas Germer, Ingo Hartlapp, Hermann Einsele et al.|Onkologie|2013Cited by 0